Law Office of Brodsky & Smith, LLC Announces Investigation of Synovis Life Technologies, Inc.
15 12월 2011 - 7:24AM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Synovis Life Technologies, Inc. (“Synovis” or the “Company”)
(Nasdaq: SYNO) relating to the proposed acquisition by Baxter
International, Inc. (“Baxter”) (NYSE: BAX).
Under the terms of the transaction, Synovis shareholders would
receive $28.00 in cash for each share of Synovis common stock they
own. The transaction has a total approximate value of $325 million.
The investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of Synovis
for not acting in Synovis shareholders' best interests in
connection with the sale process to Baxter.
If you own shares of Synovis and wish to discuss the legal
ramifications of the proposed transaction, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Evan J.
Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/369-syno-synovis-life-technologies-inc.html,
or by calling toll free 877-LEGAL-90.
Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Synovis Life Technologies, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Brodsky & Smith, LLC News Articles